RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
UROLOGIC ONCOLOGY
Collezione AOU Città della Salute di Torino

Items : 13

The presence of intraductal carcinoma of prostate is a risk factor for poor pathologic response in men with high-risk prostate cancer receiving neoadjuvant therapy. in Urologic oncology / Urol Oncol. 2024 Mar;42(3):67.e9-67.e15. doi: 10.1016/j.urolonc.2023.11.018. Epub 2024 Jan 17.

2024
AOU Città della Salute di Torino

Guo H; Zhang S; Zhuang J; Marra G; Peng S; Fu Y; Chen M; Wang B; Qiu X;

Impact of the time elapsed between prostate biopsy and surgery on the accuracy of nomograms predicting lymph node invasion in patients with clinically localized prostate cancer. in Urologic oncology / Urol Oncol. 2023 Sep;41(9):387.e17-387.e25. doi: 10.1016/j.urolonc.2023.04.019. Epub 2023 May 16.

2023
AOU Città della Salute di Torino

Montorsi F; Ploussard G; Minervini A; Gontero P; Guo H; Scuderi S; Barletta F; Rosiello G; Sorce G; Zhuang J; Afferi L; Campi R; Beauval JB; Marra G; Stabile A; Mazzone E; Pellegrino F; Briganti A; Gandaglia G;

Diagnostic accuracy of preoperative lymph node staging of bladder cancer according to different lymph node locations: A multicenter cohort from the European Association of Urology - Young Academic Urologists. in Urologic oncology / Urol Oncol. 2022 May;40(5):195.e27-195.e35. doi: 10.1016/j.urolonc.2022.01.002. Epub 2022 Feb 27.

2022
AOU Città della Salute di Torino

Krajewski W; Poyet C; Rink M; Ammiwala M; Hendricksen K; Pradere B; Shariat SF; Gontero P; Soria F; Marra G; Simeone C; Zamboni S; Simone G; Karnes RJ; Briganti A; Montorsi F; Colombo R; Necchi A; Di Trapani E; De Cobelli O; Mordasini L; Afferi L; Lonati C; Baumeister P; Mattei A; Moschini M; Carando R;

Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy? in Urologic oncology / Urol Oncol. 2022 Jun;40(6):273.e11-273.e20. doi: 10.1016/j.urolonc.2022.01.008. Epub 2022 Feb 23.

2022
AOU Città della Salute di Torino

Laukhtina E; Buisan O; Krajewski W; Hendricksen K; Terrone C; Roumiguie M; Umari P; Francavilla S; Galfano A; Shariat SF; D'Andrea D; Simone G; Poyet C; Hurle R; Contieri R; Sanchez-Salas R; Colomer A; Karnes RJ; Antonelli A; Tafuri A; Mattei A; Carando R; Ornaghi PI; Afferi L; Montorsi F; Briganti A; Soria F; Simeone C; Rink M; et alii...

Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus. in Urologic oncology / Urol Oncol. 2021 Nov;39(11):781.e17-781.e24. doi: 10.1016/j.urolonc.2021.01.027. Epub 2021 Mar 4.

2021
AOU Città della Salute di Torino

Sidana A; Song DY; Pinto PA; Marra G; Marks LS; Lebastchi AH; Katz AE; Gupta RT; Gill IS; George AK; Feller JF; Emberton M; Carroll PR; Klotz L; Tan WP; Rastinehad AR; Ward JF; Sanchez-Salas R; Rosette J; Polascik TJ;

Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassifications. in Urologic oncology / Urol Oncol. 2021 May;39(5):296.e1-296.e9. doi: 10.1016/j.urolonc.2020.08.030. Epub 2020 Oct 9.

2021
AOU Città della Salute di Torino

Peltier A; Simone G; Descotes JL; Fiard G; Iselin C; Benamran D; Fournier G; Fourcade A; Gontero P; Oderda M; Malavaud B; Roumiguié M; Ploussard G; Diamand R; Roche JB; Roumeguère T; Albisinni S;

Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study. in Urologic oncology / Urol Oncol. 2021 May;39(5):296.e21-296.e29. doi: 10.1016/j.urolonc.2020.11.002. Epub 2021 Jan 10.

2021
AOU Città della Salute di Torino

Berger A; Aron M; Fiscus G; Joshi S; Smith J; Mottrie A; Vidit S; Gandaglia G; Morlacco A; Albisinni S; van Velthoven R; Roupret M; Taille A; Piechaud T; Smelzo S; Joniau S; Palou J; Persad R; Gillatt D; Cahill D; Popert R; Challacombe B; Dasgupta P; Goonewardene S; Sanchez-Salas R; Linares E; Ricardi U; Filippini C; Munoz F; et alii...

External validation of the Briganti nomogram predicting lymph node invasion in patients with intermediate and high-risk prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies: A European multicenter study. in Urologic oncology / Urol Oncol. 2020 Nov;38(11):847.e9-847.e16. doi: 10.1016/j.urolonc.2020.04.011. Epub 2020 May 26.

2020
AOU Città della Salute di Torino

Bonnal JL; Van Damme J; Roche JB; Di Cosmo G; Simone G; Peltier A; Svistakov I; Assenmacher G; Descotes JL; Fiard G; Iselin C; Benamran D; Fournier G; Fourcade A; Albisinni S; Oderda M; Diamand R; Rossi M; Mandron E; Gontero P; Roumeguère T;

Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019? in Urologic oncology / Urol Oncol. 2020 May;38(5):440-448. doi: 10.1016/j.urolonc.2019.10.002. Epub 2019 Nov 5.

2020
AOU Città della Salute di Torino

van der Heijden AG; Burger M; Evert M; Hulsbergen-van de Kaa CA; Zlotta AR; Hacek J; Dominguez-Escrig JL; Zigeuner R; Nieuwenhuijzen JA; Mostafid AH; Shariat SF; Haitel A; Rouprêt M; Coté JF; Volanis D; Sheikh SE; Cussenot O; Lunelli L; Cohen D; Mertens LS; Cotte J; Huebner N; Ashabere D; Kusuma VRM; Mannweiler S; Bosschieter J; Seles M; Rubio-Briones J; Calatrava A; et alii...

Segmental ureterectomy vs. radical nephroureterectomy for ureteral carcinoma in patients with a preoperative glomerular filtration rate less than 90 ml/min/1.73 m(2): A multicenter study. in Urologic oncology / Urol Oncol. 2020 Jun;38(6):601.e11-601.e16. doi: 10.1016/j.urolonc.2020.03.005. Epub 2020 Apr 6.

2020
AOU Città della Salute di Torino

Abrate A; Sessa F; Campi R; Preto M; Olivero A; Varca V; Benelli A; Sessa M; Sebastianelli A; Pavone C; Serretta V; Vella M; Brunocilla E; Serni S; Trombetta C; Terrone C; Gregori A; Lissiani A; Gontero P; Schiavina R; Gacci M; Simonato A;

The prognostic value of basal DNA damage level in peripheral blood lymphocytes of patients affected by bladder cancer. in Urologic oncology / Urol Oncol. 2018 May;36(5):241.e15-241.e23. doi: 10.1016/j.urolonc.2018.01.006. Epub 2018 Feb 14.

2018
AOU Città della Salute di Torino

Allione A; Pardini B; Viberti C; Oderda M; Allasia M; Gontero P; Vineis P; Sacerdote C; Matullo G;

Is imperative partial nephrectomy feasible for kidney cancer with venous thrombus involvement? Outcomes of 42 cases and matched pair analysis with a large radical nephrectomy cohort. in Urologic oncology / Urol Oncol. 2018 Jul;36(7):339.e1-339.e8. doi: 10.1016/j.urolonc.2018.04.007. Epub 2018 May 24.

2018
AOU Città della Salute di Torino

Marra G; Libertino JA; McKiernan JM; Zigeuner R; Martínez-Salamanca JI; Linares Espinós E; Daneshmand S; Huang WC; Montorsi F; Capitanio U; Filippini C; Brattoli M; Marra G; Gontero P; Gontero P; Brattoli M; Filippini C; Capitanio U; Montorsi F; Daneshmand S; Huang WC; Linares Espinós E; Martínez-Salamanca JI; McKiernan JM; Zigeuner R; Libertino JA;

Focal therapy in localised prostate cancer: Real-world urological perspective explored in a cross-sectional European survey. in Urologic oncology / Urol Oncol. 2018 Dec;36(12):529.e11-529.e22. doi: 10.1016/j.urolonc.2018.08.013. Epub 2018 Oct 6.

2018
AOU Città della Salute di Torino

Marra G; Ploussard G; Ost P; De Visschere PJL; Briganti A; Gandaglia G; Tilki D; Surcel CI; Tsaur I; Van Den Bergh RCN; Kretschmer A; Borgmann H; Gontero P; Ahmed HU; Valerio M; Marra G; Ploussard G; Ost P; De Visschere PJL; Briganti A; Gandaglia G; Tilki D; Surcel CI; Tsaur I; Van Den Bergh RCN; Kretschmer A; Borgmann H; Gontero P; Ahmed HU; et alii...